TickerGuard
Buy Day today: Poor (52) Mixed market breadth · today: Core PCE (August) ≈
BCRX

BioCryst Pharmaceuticals Inc

Healthcare · Drug Manufacturers - Specialty & Generic

8.50$ -0.6% vs. previous close Closing price · As of: Sep 24, 2026

Statements

Balance Sheet

BioCryst Pharmaceuticals Inc (BCRX) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 558 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios
Annual Quarterly
Amounts Change % Common size %
Last 12 Full history
Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet BCRX
Line item Q3 16 Q4 16 Q1 17 Q2 17 Q3 17 Q4 17 Q1 18 Q2 18 Q3 18 Q4 18 Q1 19 Q2 19 Q3 19 Q4 19 Q1 20 Q2 20 Q3 20 Q4 20 Q1 21 Q2 21 Q3 21 Q4 21 Q1 22 Q2 22 Q3 22 Q4 22 Q1 23 Q2 23 Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
92 90 130 114 191 178 155 137 168 147 142 116 91 175 137 215 176 335 284 277 266 588 528 511 559 550 510 530 523 517 468 472 491 490 480 457 446 514 465 558
65 67 114 92 175 125 104 93 128 114 118 104 79 164 126 204 162 324 274 266 253 566 512 495 509 517 491 414 502 496 447 363 427 422 410 398 356 404 374 485
35 22 75 40 118 50 44 27 53 27 35 31 30 114 102 173 96 272 227 210 200 504 396 273 247 305 155 146 151 111 84 78 98 105 105 88 84 90 172 155
67 64 102 90 166 156 91 114 149 127 119 93 68 136 113 189 143 300 240 218 200 508 443 417 427 424 402 414 398 389 337 272 331 321 295 260 213 275 239 353
6.0 8.8 9.6 3.3 9.0 6.1 5.7 2.3 3.4 4.3 5.0 3.6 3.6 22 5.6 4.0 5.4 8.6 18 28 26 29 36 41 43 51 49 -365 54 57 61 69 72 79 93 91 91 107 109 111
2.2 0.5 0.7 1.3 -1.2 -38 0.0 0.2 0.8 1.6 0.6 1.0 1.8 1.6 1.6 5.2 6.2 7.0 5.1 9.8 14 16 16 23 27 28 27 27 30 29 30 4.5 7.6 8.1 6.9 5.0 5.2 5.4 6.0 6.1
10 9.9 9.8 9.6 9.6 9.5 9.4 9.4 9.2 9.1 7.6 7.6 7.5 7.3 7.3 7.1 7.1 7.1 7.0 11 7.8 15 8.8 8.7 8.5 15 8.4 8.4 – – – – – – – – – – – –
0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – –
0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – –
88 88 91 89 91 94 93 90 95 98 120 126 132 137 133 138 143 354 359 383 413 695 692 724 801 845 838 919 934 972 944 948 960 966 932 879 834 633 1,019 1,012
52 54 59 59 69 75 75 74 64 69 66 72 82 92 93 103 112 106 101 116 134 104 81 95 82 106 85 93 91 150 120 129 154 160 140 177 190 196 195 209
28 28 30 31 33 35 35 36 31 34 29 29 35 40 45 50 50 31 31 31 31 1.8 2.1 2.1 2.2 2.4 2.5 2.5 2.3 2.6 2.7 2.7 36 35 37 2.0 39 1.6 43 3.0
2.8 4.3 5.4 1.8 4.6 6.3 3.6 4.1 7.9 7.8 6.9 8.3 10 14 10 9.4 12 19 14 10 20 28 14 12 8.6 14 6.3 14 11 21 12 7.8 13 12 10 8.6 5.6 16 11 11
25 25 24 23 21 20 15 13 28 25 50 50 46 41 37 32 27 120 123 127 132 585 140 145 224 733 233 293 833 811 813 808 796 796 782 691 633 427 802 778
4.0 1.6 39 24 101 84 62 46 73 49 23 -9.2 -41 38 3.6 77 34 -19 -75 -106 -147 -107 -164 -213 -243 -295 -1,508 -1,583 -411 -456 -476 -476 -469 -476 -452 -422 -388 -119 -554 -454
-562 -566 -580 -597 -612 -632 -656 -675 -705 -732 -763 -800 -838 -841 -878 -917 -963 -1,023 -1,088 -1,131 -1,190 -1,208 -1,282 -1,341 -1,383 -1,455 -1,508 -1,583 -1,619 -1,681 -1,717 -1,729 -1,743 -1,770 -1,770 -1,765 -1,752 -1,506 -2,228 -2,150
74 74 75 80 84 98 99 99 105 110 110 110 110 131 154 162 177 177 177 178 179 182 185 186 186 187 189 189 190 201 206 206 207 207 215 220 220 219 242 265

Showing the most recent 40 periods — older statements are on file for this stock.

Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?